USNZ:NYE-DBX ETF Trust - Xtrackers Net Zero Pathway Paris Aligned US Equity ETF (USD)

ETF | Others |

Last Closing

USD 32.5

Change

+0.27 (+0.83)%

Market Cap

USD 0.18B

Volume

0.01M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-02 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE SOJE

-0.05 (-0.25%)

USD 65.72B
JEPI JPMorgan Equity Premium Income..

+0.02 (+0.03%)

USD 33.68B
DFAC Dimensional U.S. Core Equity 2..

-0.13 (-0.40%)

USD 27.49B
DTB DTB

-0.13 (-0.67%)

USD 26.58B
GBTC Grayscale Bitcoin Trust (BTC)

-0.80 (-1.36%)

USD 23.75B
JPST JPMorgan Ultra-Short Income ET..

+0.01 (+0.02%)

USD 23.09B
SGOV iShares® 0-3 Month Treasury B..

+0.05 (+0.05%)

USD 20.81B
AVUV Avantis® U.S. Small Cap Value..

-0.48 (-0.51%)

USD 11.25B
DFUV Dimensional US Marketwide Valu..

-0.08 (-0.20%)

USD 10.54B
DFAT Dimensional U.S. Targeted Valu..

-0.30 (-0.55%)

USD 9.93B

ETFs Containing USNZ

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 5.38% 75% C 70% C-
Dividend Return 0.24% 15% F 11% F
Total Return 5.62% 74% C 67% D+
Trailing 12 Months  
Capital Gain 22.96% 77% C+ 74% C
Dividend Return 0.95% 14% F 10% F
Total Return 23.92% 77% C+ 71% C-
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 8.66% 90% A- 68% D+
Dividend Return 8.98% 89% A- 62% D
Total Return 0.32% 21% F 8% B-
Risk Return Profile  
Volatility (Standard Deviation) 10.99% 39% F 79% B-
Risk Adjusted Return 81.68% 98% N/A 95% A
Market Capitalization 0.18B 73% C 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.